UnknownNot Applicable

Vaccination Against COVID-19 in Chronic Kidney Disease

Germany400 participantsStarted 2020-12-21

Plain-language summary

This is a prospective, multi-center, observational study that will enroll patients receiving dialysis (hemodialysis or peritoneal dialysis) or patients with kidney transplantation who will be vaccinated against COVID-19.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * receiving dialysis (hemodialysis or peritoneal dialysis) * capable of giving consent * age 18 or older Exclusion Criteria: \- non-capable of giving consent

What they're measuring

SARS-CoV-2- antibody- titer

Timeframe: 2 years

Trial details

NCT IDNCT04743947

SponsorHeinrich-Heine University, Duesseldorf

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Johannes Stegbauer, MD

+492118117502 johannes.stegbauer@med.uni-duesseldorf.de

View on ClinicalTrials.gov More Chronic Kidney Disease Stage 5 on Dialysis trials